Cargando…
Mesenchymal gene expression subtyping analysis for early-stage human papillomavirus-negative head and neck squamous cell carcinoma reveals prognostic and predictive applications
Patients with oral cavity squamous cell carcinoma (OCSCC) are predominantly human papillomavirus (HPV)(−), and treatment typically involves surgical resection ± neck dissection, followed by radiation ± chemotherapy. We previously described four mRNA expression patterns (classical, atypical, basal, a...
Autores principales: | Mayhew, Gregory M., Uronis, Joshua M., Hayes, David Neil, Zevallos, Jose P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486405/ https://www.ncbi.nlm.nih.gov/pubmed/36147910 http://dx.doi.org/10.3389/fonc.2022.954037 |
Ejemplares similares
-
Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma
por: Zhou, Ping, et al.
Publicado: (2021) -
Multimodal Dimension Reduction and Subtype Classification of Head and Neck Squamous Cell Tumors
por: Bard, Jonathan E., et al.
Publicado: (2022) -
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
por: Jamieson, Stephen M.F., et al.
Publicado: (2023) -
p63 Directs Subtype-Specific Gene Expression in HPV+ Head and Neck Squamous Cell Carcinoma
por: Glathar, Alexandra Ruth, et al.
Publicado: (2022) -
Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)